American Rebel Holdings Inc
Change company Symbol lookup
Select an option...
AREB American Rebel Holdings Inc
VTN Invesco Trust for New York Investment Grade Municipals
VVR Invesco Senior Income Trust
CLX Clorox Co
SNCY Sun Country Airlines Holdings Inc
NCZ Virtus Convertible & Income Fund II
XPEV Xpeng Inc
PTON Peloton Interactive Inc
PEB Pebblebrook Hotel Trust

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Industrials : Commercial Services & Supplies | Small Cap Value
Company profile

American Rebel Holdings, Inc. operates primarily as a designer and marketer of branded safes and personal security and self-defense products. The Company designs and produces branded accessories and apparel, including concealment pockets. It offers an assortment of personal security products, as well as apparel and accessories for men and women under the Company’s American Rebel brand. Its products are designed to store firearms, as well as store its customers’ keepsakes, family heirlooms and treasured memories. It offers a range of concealed carry jackets, vests and coats for men and women. The Company’s apparel collection consists of Cartwright Coats and Vests, Freedom 2.0 Jackets and Vests and American Rebel T-Shirts Collection. Its safe collection consists of six safes in a range of sizes: AR-50, AR-40, AR-30, AR-20, AR-15 and AR-12. The Company is also a manufacturer of gun safes with security and fire protection.

Closing Price
Day's Change
0.0006 (0.24%)
B/A Size
Day's High
Day's Low

10-day average volume:

Zentek Announces Annual General Meeting on Thursday September 29th, 2022, at the Delta Hotel in Guelph, Ontario

8:03 am ET September 8, 2022 (Accesswire) Print

GUELPH, ON / ACCESSWIRE / September 8, 2022 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce its 2022 Annual General and Special Meeting will be held on Thursday, September 29th at 4:00 pm at the Delta Hotel in Guelph, Ontario. Capacity may be limited, and attendees must register by email at The meeting will be live streamed for those who cannot attend in person, with details to be provided at a later date.

"We look forward to meeting our shareholders once again to discuss the Company's achievements in the last year, the direction of the Company going forward, answer shareholder questions and to vote on important matters that will allow the board and management team to best move the Company forward," said Dr. Francis Dubé, Executive Chairman for Zentek.

The Management Information Circular will be mailed shortly to shareholders of record on Friday August 25th. Shareholders will be asked to vote on the following items:

  • to appoint BDO as the auditors of the Company for the ensuing year and to authorize the directors to fix their remuneration;
  • to elect the directors of the Company for the ensuing year;
  • to consider, and, if deemed advisable, to pass an ordinary resolution approving the adoption of the Company's omnibus long-term incentive plan;
  • to consider, and, if deemed advisable, pass, with or without variation, a special resolution authorizing the directors to change the registered address of the Company;
  • to transact such other business as may properly come before the meeting or any adjournments or postponements thereof.

The nature of the business to be transacted at the meeting is described in further detail in the management information circular of the Company under the section entitled Matters to be Acted Upon, was sent to shareholders commencing on or around September 7, 2022.

For more information, visit

About Zentek Ltd.

Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. Zentek is currently focused on commercializing ZenGUARDT, a patent-pending coating shown to have 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as products against infectious diseases. The Company also has an exclusive agreement to be the global exclusive commercializing partner for a newly developed aptamer-based rapid pathogen detection technology.

For further information:

Tyler Dunn

Tel: (306)717-6745


Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Zentek

View source version on

comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.